A randomized controlled trial to investigate whether decrease in visceral adipose tissue in human

A randomized controlled trial to investigate whether decrease in visceral adipose tissue in human - A trial to investigate whether decrease in visceral adipose tissue in human

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014526

Enrollment

Registered

2014-07-09

Start date

2014-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 12 weeks Test material: PROTON GRAN PRO shape and size capsule (standard: size 2) take two capusles twice daily both before breakfast and going to bed during fasting Duration: 12 weeks T

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) Persons whose ages are ranging from 30 to 49 years old b) Persons whose BMIs are 25 or larger c) Persons who stop intaking other supplements during the test if he/she intakes supplement and nutrient enrichment food habitually d) Persons who had alcohol drinking less than twice a week e) Persons who sport less than twice a week

Exclusion criteria

Exclusion criteria: a) Persons who have previous medical history of malignancy, heart failure or myocardial infarction b) Patients being treated for at least one of following diseases; atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and other chronic disease c) Persons who take medicines, herbal medicines d) Persons who are allergic to medicines, or foods related to the test material of this trial e) Persons who take medicines in relation to pollinosis during the trial period f) Pregnant women, lactating women, or women who want to get pregnant during the trial period g) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial h) Persons who are to work or activities in the night i) Persons who are judged not suitable to participate in this trial by physician.

Design outcomes

Primary

Measure	Time frame
Computed Tomography Total abdominal adipose tissue area Subcutaneous adipose tissue area Visceral adipose tissue area	—

Secondary

Measure	Time frame
subjective symptom Likert scales blood chemical analysis Total cholesterol HDL cholesterol LDL cholesterol Triglyceride Free fatty acid Body analysis Weight BMI Percent body fat waist circumference	—

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026